Triple-agonist (GLP-1 / GIP / glucagon) research peptide studied for metabolic pathways, appetite regulation, and body composition research.
Dual GIP/GLP-1 receptor agonist studied for appetite control, glucose response, and body-weight management in non-clinical research applications.
Same TZ research compound in a mid-strength option for ongoing non-clinical research applications.
Entry-level TZ research peptide commonly used in metabolic and weight-management studies in laboratory settings.
Nootropic research peptide studied for cognitive performance pathways in laboratory research.
Research peptide commonly explored in laboratory settings for stress-response and neurobehavioral pathways.
Advanced recovery and wellness research blend formulated with 50mg BPC-157, 10mg GHK-Cu, and 10mg TB-500.
Research peptide commonly studied in non-clinical laboratory settings related to neuroendocrine pathways.
3 mL of bacteriostatic water for reconstituting freeze-dried research compounds.
